Closed tender · Czechia · Medicinal products for the blood and blood-forming organs
Hemofilie A - Rekombinantní faktor VIII. 2026
In EnglishHemophilia A - Recombinant Factor VIII. 2026
Fakultní nemocnice Olomouc in Czechia invited bids for “Hemophilia A - Recombinant Factor VIII. 2026”. Bids closed on 9 October 2026, 10:00 CEST; the estimated value is CZK 122 million.
Key facts
- Estimated value
- CZK 122 million
- Procedure
- Contract notice
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences